APA (7th ed.) Citation

Joshua MacAusland-Berg, Amy Wiebe, Radhika Marwah, & Katelyn Halpape. (2022). Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: A case report. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Joshua MacAusland-Berg, Amy Wiebe, Radhika Marwah, and Katelyn Halpape. Successful Conversion from Butorphanol Nasal Spray to Buprenorphine/naloxone Using a Low-dose Regimen to Assist with Opioid Tapering in the Setting of Chronic Pain and Migraine Management in an Older Adult Patient: A Case Report. Taylor & Francis Group, 2022.

MLA (9th ed.) Citation

Joshua MacAusland-Berg, et al. Successful Conversion from Butorphanol Nasal Spray to Buprenorphine/naloxone Using a Low-dose Regimen to Assist with Opioid Tapering in the Setting of Chronic Pain and Migraine Management in an Older Adult Patient: A Case Report. Taylor & Francis Group, 2022.